世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

がん悪液質市場:世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測


Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

世界のがん悪液質の市場規模は、2022年に2.0ビリオン米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に4.5%の成長率(CAGR)を示し、2028年までに26億米ドルに達すると予測しています。 がん... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス
2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
143 英語

 

サマリー

世界のがん悪液質の市場規模は、2022年に2.0ビリオン米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に4.5%の成長率(CAGR)を示し、2028年までに26億米ドルに達すると予測しています。

がん悪液質とは、組織的な炎症、除脂肪体重の不随意的な減少、負のタンパク質バランス、食欲不振、筋萎縮を特徴とする多因子の宿主貪食性消耗性症候群を指します。結核、多発性硬化症、慢性閉塞性肺疾患(COPD)、ヒト免疫不全ウイルス(HIV)などの様々な慢性疾患の発生により引き起こされます。癌性悪液質は、黄体ホルモン剤、副腎皮質ホルモン剤、併用療法などの様々な治療薬を用いて治療することができる。このうち、黄体ホルモンは食欲を増進させ体重増加を促す合成または天然のステロイドホルモンであり、副腎皮質ホルモンは炎症を緩和し、過剰な免疫系を抑制する働きがある。

癌性悪液質の市場動向:
癌と悪液質の有病率の増加、特に老年人口の増加により、先進的な治療法と薬剤の需要が促進され、それが市場成長の主な原動力となっています。さらに、癌性悪液質を治療するための新しい治療薬の利用可能性に関する消費者の意識の高まりも、これを後押ししています。さらに、薬物療法、非薬物療法、臨床試験を通じて除脂肪体重(LBM)を改善するための併用療法に患者が傾倒していることも、成長を促進する要因となっています。また、消化を改善するために、酢酸メゲストロール、デキサメタゾン、メチルプレドニゾロンなどの食欲増進剤が広く使用されていることも、市場の成長に寄与しています。さらに、がん性悪液質治療のための効果的な医薬品の開発に重点を置いた著しい技術的進歩が、市場の成長をさらに後押ししています。これとは別に、各国の政府機関や非政府組織(NGO)が、がん性悪液質の原因やその症状、先進的な治療法の利点について人々を啓発するために行っている数々の好ましい取り組みが、市場に明るい展望をもたらしている。

主要な市場セグメンテーション
IMARC Groupは、世界の癌性悪液質市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、治療薬、作用機序、流通チャネルに基づき市場を分類しています。

治療薬別構成比:

プロゲストーゲン
コルチコステロイド
併用療法について
その他

作用機序による分解:

食欲増進剤(アペタイトスティミュレーター
ウェイトロススタビライザー

流通チャネル別構成比:

ホスピタルストア
リテールファーマシー
オンラインファーマシー

地域別構成比:

北アメリカ
ユーエスエー
カナダ
アジア太平洋
中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中近東・アフリカ

競争環境:
業界の競争環境は、AAVogen Inc.、Actimed Therapeutics Ltd.、Aphios Corporation、Artelo Biosciences Inc.、AVEO Pharmaceuticals Inc.、Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co.Inc.、NGM Biopharmaceuticals Inc.、Pfizer Inc.、Tetra Bio-Pharma。

本レポートで回答した主な質問
世界のがん悪液質市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
COVID-19が世界のがん性悪液質市場に与えた影響は?
主要な地域市場とは?
治療薬に基づく市場のブレークアップは?
作用機序に基づく市場のブレークアップは?
販売チャネルに基づく市場の内訳は?
業界のバリューチェーンにおける様々なステージは何か?
業界における主要な推進要因と課題は何か?
世界のがん性悪液質市場の構造と主要プレイヤーは誰か?
業界における競争の度合いはどの程度か?

ページTOPに戻る


目次

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Cancer Cachexia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapeutics
    6.1    Progestogens
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Corticosteroids
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Combination Therapy
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Mode of Action
    7.1    Appetite Stimulators
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Weight Loss Stabilizers
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Stores
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AAVogen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Actimed Therapeutics Ltd.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Aphios Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Artelo Biosciences Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    AVEO Pharmaceuticals Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Fresenius Kabi AG (Fresenius SE & Co. KGaA)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    Helsinn Healthcare SA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Merck & Co. Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    NGM Biopharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Pfizer Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Tetra Bio-Pharma
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2022
Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2022
Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2022
Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2023-2028
Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2023-2028
Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cancer Cachexia Market: Competitive Structure
Table 7: Global: Cancer Cachexia Market: Key Players

 

ページTOPに戻る


 

Summary

The global cancer cachexia market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2023-2028.

Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.

Cancer Cachexia Market Trends:
The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer cachexia market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapeutics, mode of action and distribution channel.

Breakup by Therapeutics:

Progestogens
Corticosteroids
Combination Therapy
Others

Breakup by Mode of Action:

Appetite Stimulators
Weight Loss Stabilizers

Breakup by Distribution Channel:

Hospital Stores
Retail Pharmacy
Online Pharmacy

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.

Key Questions Answered in This Report:
How has the global cancer cachexia market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cancer cachexia market?
What are the key regional markets?
What is the breakup of the market based on the therapeutics?
What is the breakup of the market based on the mode of action?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cancer cachexia market and who are the key players?
What is the degree of competition in the industry?



ページTOPに戻る


Table of Contents

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Cancer Cachexia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapeutics
    6.1    Progestogens
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Corticosteroids
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Combination Therapy
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Mode of Action
    7.1    Appetite Stimulators
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Weight Loss Stabilizers
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Stores
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AAVogen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Actimed Therapeutics Ltd.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Aphios Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Artelo Biosciences Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    AVEO Pharmaceuticals Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Fresenius Kabi AG (Fresenius SE & Co. KGaA)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    Helsinn Healthcare SA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Merck & Co. Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    NGM Biopharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Pfizer Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Tetra Bio-Pharma
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2022
Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2022
Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2022
Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2023-2028
Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2023-2028
Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cancer Cachexia Market: Competitive Structure
Table 7: Global: Cancer Cachexia Market: Key Players

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD(cancer)の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/25 10:25

158.38 円

165.32 円

201.48 円

ページTOPに戻る